INTRODUCTION
Ultra performance liquid chromatography TM (UPLC) takes advantage of technological strides made in particle chemistry performance, system optimization, detector design, and data processing and control. Using sub-2 mm particles and mobile phases at high linear velocities, and instrumentation that operates at higher pressures than those used in HPLC, dramatic increases in resolution, sensitivity, and speed of analysis can be obtained. This new category of analytical separation science retains the practicality and principles of HPLC while creating a step function improvement in chromatographic performance.
1
According to an FDA guidance document, a stability-indicating method is "a validated quantitative analytical procedure that can detect the changes with time in the pertinent properties of the drug substance and drug product. A stability-indicating method accurately measures the active ingredients, without interference from degradation products, process impurities, excipients, or other potential impurities." 2 Moxifloxacin is slightly yellow crystalline monohydrochloride salt. 3 Moxifloxacin Hydrochloride is designated chemically as ((1'S,6'S)-1-Cyclopropyl-7-(2,8-diazabicyclo [4.3 .0]non-8-yl)-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride with an empirical formula of C 21 H 24 FN 3 O 4 . HCl and a molecular weight of 437.90. (Fig.1) 4 . Moxifloxacin can be used to treat respiratory infections, including acute sinusitis, acute exacerbations of chronic bronchitis, and community-acquired pneumonia, as well as skin and skin structure infections. Moxifloxacin is also used for the treatment of complicated intraabdominal infections.
5 . Moxifloxacin inhibits bacterial topoisomerase II (DNA gyrase) and topoisomerase IV. Topoisomerases are essential enzymes which play a crucial role in the replication 
RESULTS & DISCUSSION

Specificity:
Specificity is the ability to assess unequivocally the analyte in the presence of components which may be expected to be present. Typically these might include impurities, degradants, matrix, etc. Page147 specificity was also demonstrated by induced degradation of Moxifloxacin formulation and placebo samples to acid degradation, alkali degradation, peroxide degradation, thermal degradation, water degradation, U.V. degradation.
Purity angle is less than purity threshold for all the stress conditions. The results are tabulated in 
Page150
Linearity:
The linearity of an analytical procedure is its ability (within a given range) to obtain test results which are directly proportional to the concentration (amount) of analyte in the sample [6] . 
Limit of detection (LOD) and limit of quantification (LOQ):
The detection limit of an individual analytical procedure is the lowest amount of analyte in a sample which can be detected but not necessarily quantitated as an exact value. The quantitation limit of an individual analytical procedure is the lowest amount of analyte in a sample which can be quantitatively determined with suitable precision and accuracy [6] . Calculated the LOD & LOQ, with the calculations obtained from evaluation of the calibration curve of the linearity. LOD and LOQ values are less than the minimum linearity concentration. 
The calculations and results are tabulated in
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Accuracy:
The accuracy of an analytical procedure expresses the closeness of agreement between the value which is accepted either as a conventional true value or an accepted reference value and the value found [6] . Performed the accuracy of test method using Moxifloxacin placebo at 50%, 70%, 100%, 125%, 150% spike levels. The % assay at each spike level was found to be between 98.0-102.0% of the labeled amount. The results are tabulated in Table No 
Robustness:
The robustness of an analytical procedure is a measure of its capacity to remain unaffected by small, but deliberate variations in method parameters and provides an indication of its reliability during normal usage [6] . Robustness was performed by injecting the Moxifloxacin standard solution in to the UPLC by altering the Flow rate, Column oven temperature and also by changing the pH of the buffer & composition of the organic solvent from the normal chromatographic conditions. The results are tabulated in Table No.10   Table- 
